Studies completed and patent application submitted
The first two experimental studies on a new set of vectors have been successfully completed during January, paving the way for two subsequent studies which started February 1st at Lund and Copenhagen universities on behalf of CombiGene. A patent application was submitted February 12th , comprising the DNA sequences and other features of these new vectors.The two completed animal studies, one of which was made at Lund and Copenhagen universities in collaboration and the other at CombiGene’s subcontractor GeneDetect on New Zealand, concerned the in vivo expression of the two transgenes NPY